Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 386

1.

Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities.

Uhl GR.

Ann Clin Transl Neurol. 2019 Jan 8;6(2):406-415. doi: 10.1002/acn3.707. eCollection 2019 Feb. Review.

2.

Repeated methamphetamine treatment increases spine density in the nucleus accumbens of serotonin transporter knockout mice.

Kasahara Y, Sakakibara Y, Hiratsuka T, Moriya Y, Lesch KP, Hall FS, Uhl GR, Sora I.

Neuropsychopharmacol Rep. 2019 Feb 4. doi: 10.1002/npr2.12049. [Epub ahead of print]

3.

PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Uhl GR, Martinez MJ.

Ann N Y Acad Sci. 2019 Jan 15. doi: 10.1111/nyas.14002. [Epub ahead of print] Review.

PMID:
30648269
4.

The neurobiology of addiction.

Uhl GR, Koob GF, Cable J.

Ann N Y Acad Sci. 2019 Jan 15. doi: 10.1111/nyas.13989. [Epub ahead of print]

PMID:
30644552
5.

Brain hyperserotonemia causes autism-relevant social deficits in mice.

Tanaka M, Sato A, Kasai S, Hagino Y, Kotajima-Murakami H, Kashii H, Takamatsu Y, Nishito Y, Inagaki M, Mizuguchi M, Hall FS, Uhl GR, Murphy D, Sora I, Ikeda K.

Mol Autism. 2018 Nov 26;9:60. doi: 10.1186/s13229-018-0243-3. eCollection 2018.

6.

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.

Uhl GR, Martinez MJ, Paik P, Sulima A, Bi GH, Iyer MR, Gardner E, Rice KC, Xi ZX.

Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11597-11602. doi: 10.1073/pnas.1720446115. Epub 2018 Oct 22.

PMID:
30348770
7.

Larger Numbers of Glial and Neuronal Cells in the Periaqueductal Gray Matter of μ-Opioid Receptor Knockout Mice.

Sasaki K, Hall FS, Uhl GR, Sora I.

Front Psychiatry. 2018 Sep 19;9:441. doi: 10.3389/fpsyt.2018.00441. eCollection 2018.

8.

The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders.

Rabinowitz JA, Musci RJ, Milam AJ, Benke K, Uhl GR, Sisto DY, Ialongo NS, Maher BS.

Drug Alcohol Depend. 2018 Oct 1;191:365-373. doi: 10.1016/j.drugalcdep.2018.07.016. Epub 2018 Aug 25.

PMID:
30195949
9.

Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.

Ide S, Ikekubo Y, Hua J, Takamatsu Y, Uhl GR, Sora I, Ikeda K.

Neuropsychopharmacol Rep. 2018 Sep;38(3):149-153. doi: 10.1002/npr2.12020. Epub 2018 Jun 29.

10.

Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex.

Kitanaka N, Kitanaka J, Hall FS, Kandori T, Murakami A, Muratani K, Nakano T, Uhl GR, Takemura M.

Pharmacol Biochem Behav. 2018 Sep;172:9-16. doi: 10.1016/j.pbb.2018.07.002. Epub 2018 Jul 12.

PMID:
30017858
11.

The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction.

Muskiewicz DE, Uhl GR, Hall FS.

Neural Plast. 2018 Feb 20;2018:9803764. doi: 10.1155/2018/9803764. eCollection 2018. Review.

12.

Psychotomimetic-like behavioral effects of memantine in the mouse.

Kitanaka N, Kitanaka J, Hall FS, Kubota Y, Mimura Y, Ogura S, Okada Y, Uhl GR, Takemura M.

Biomed Pharmacother. 2018 Apr;100:116-123. doi: 10.1016/j.biopha.2018.01.160. Epub 2018 Feb 8.

PMID:
29427922
13.

Distinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation.

Ide S, Takahashi T, Takamatsu Y, Uhl GR, Niki H, Sora I, Ikeda K.

Int J Neuropsychopharmacol. 2017 May 1;20(5):403-409. doi: 10.1093/ijnp/pyw113.

14.

Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice.

Drgonova J, Walther D, Hartstein GL, Bukhari MO, Baumann MH, Katz J, Hall FS, Arnold ER, Flax S, Riley A, Rivero-Martin O, Lesch KP, Troncoso J, Ranscht B, Uhl GR.

Mol Med. 2016 Oct;22:537-547. doi: 10.2119/molmed.2015.00170. Epub 2016 Aug 18.

15.
16.

Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Takemura M.

Drug Target Insights. 2016 Mar 2;10:1-7. doi: 10.4137/DTI.S38342. eCollection 2016. Review.

17.

Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.

Kitanaka N, Kitanaka J, Hall FS, Kayama M, Sugimori H, Uhl GR, Takemura M.

J Exp Neurosci. 2015 Sep 10;9(Suppl 1):1-10. doi: 10.4137/JEN.S27733. eCollection 2015.

18.

Mouse Model for Protein Tyrosine Phosphatase D (PTPRD) Associations with Restless Leg Syndrome or Willis-Ekbom Disease and Addiction: Reduced Expression Alters Locomotion, Sleep Behaviors and Cocaine-Conditioned Place Preference.

Drgonova J, Walther D, Wang KJ, Hartstein GL, Lochte B, Troncoso J, Uetani N, Iwakura Y, Uhl GR.

Mol Med. 2015 Nov;21(1):717-725. doi: 10.2119/molmed.2015.00017. Epub 2015 Jul 14.

19.

Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.

Drgonova J, Walther D, Singhal S, Johnson K, Kessler B, Troncoso J, Uhl GR.

PLoS One. 2015 Jul 14;10(7):e0120908. doi: 10.1371/journal.pone.0120908. eCollection 2015.

20.

Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genes.

Zhong X, Drgonova J, Li CY, Uhl GR.

Ann N Y Acad Sci. 2015 Sep;1349:83-95. doi: 10.1111/nyas.12776. Epub 2015 May 18. Review.

Supplemental Content

Loading ...
Support Center